Cleared Traditional

K950854 - VITALOGRAPH 2110 SOFTWARE INTERFACE (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K950854 · Vitalograph , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1995
Decision
227d
Days
Class 2
Risk

K950854 is an FDA 510(k) clearance for the VITALOGRAPH 2110 SOFTWARE INTERFACE. Classified as Recorder, Magnetic Tape, Medical (product code DSH), Class II - Special Controls.

Submitted by Vitalograph , Ltd. (Lenexa, US). The FDA issued a Cleared decision on October 12, 1995 after a review of 227 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vitalograph , Ltd. devices

Submission Details

510(k) Number K950854 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 1995
Decision Date October 12, 1995
Days to Decision 227 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 125d · This submission: 227d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSH Recorder, Magnetic Tape, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSH Recorder, Magnetic Tape, Medical

All 193
Devices cleared under the same product code (DSH) and FDA review panel - the closest regulatory comparables to K950854.
Rhythm Master ECG Patch (HM-15BB-AX, HM-15BW-AX, HM-15BW-DX)
K252389 · Smwmed, Inc. · Apr 2026
VitaloJAK Clinic (Model 7100)
K253293 · Vitalograph , Ltd. · Dec 2025
Zio® monitor (DFG0001)
K243650 · iRhythm Technologies, Inc. · Aug 2025
AeviceMD
K243603 · Aevice Health Pte. , Ltd. · May 2025
AT-Patch (ATP-C130/ATP-C70)
K242583 · Atsens Co., Ltd. · May 2025
HiCardi+ H100
K232670 · MEZOO Co., Ltd. · Sep 2024